Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenobarbital Versus Ativan for Refractory Alcohol Withdrawal Treatment in the Intensive Care Unit

NCT04156464 is registered in ClinicalTrials.gov with OSF Healthcare System as lead sponsor.

NCT NCT04156464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04156464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenobarbital Versus Ativan for Refractory Alcohol Withdrawal Treatment in the Intensive Care Unit
Lead sponsor
OSF Healthcare System
Phase
Phase 4
Overall status
Unknown status
Start date
July 6, 2020
Completion date
March 1, 2022
Enrollment
142 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol withdrawal, alcohol withdrawal delirium